Nanotechnology : Morrisville

Advanced Liquid Logic, Inc.

Benj — Thu, 01 Mar 2007 12:08:50 +0000

Ticker Id

Web url

http://www.liquid-logic.com/

Contact Email

info@liquid-logic.com

Short description

Street address

615 Davis Dr, Suite 800

Zip or postal code

27560

Telephone

919-287-9010

Fax

919-287-9011

Foundation date

Ceo, president

Number of employees

Long description

Digital microfluidics is a lab-on-a-chip approach based on direct, programmable micromanipulation of small volume droplets using electrical fields. Digital microfluidics enables complex, multi-step liquid handling protocols to be flexibly, scalably, and cost effectively implemented.

Why is digital microfluidics a fundamentally better approach?

* Programmable, software-driven, discrete electronic control of each droplet provides amazing flexibility
* The channel-less architecture is easily reconfigurable with only software changes
* Very accurate and repeatable droplet volumes lead to high quality test results
* The control equipment is small and inexpensive and extremely energy efficient
* Discrete droplet control and no channels to prime translates to efficient use of samples and reagents
* Development cycles are short using industry-standard, low cost, production-ready printed circuit board fabrication technology
* There are no pumps or valves - no moving parts at all!

Additional Commentaries and remarks

Patents

Gelest, Inc.

Benj — Wed, 08 Nov 2006 12:15:02 +0000

Ticker Id

Web url

http://www.gelest.com/

Contact Email

Short description

Street address

11 East Steel Road

Zip or postal code

19067

Telephone

(215)547-1015

Fax

(215)547-1015

Foundation date

Ceo, president

Number of employees

Long description

Since the start of Gelest, Inc., the company has continuously added experts in the fields of silanes, silicones and metal-organics. Our technical staff includes individuals with extensive hands-on experience and academic credentials (see Key Personnel below). Our customers and staff have helped increase the product listings from several hundred to the current listings of over 2000 materials.

The company has focused its research efforts toward expanding the offering of Silicon-based, Germanium-based and Tin-based products. Gelest, Inc now offers the most comprehensive selection of silane and silicone materials in the world. The company is currently expanding into a more extensive offering of other metal-organics, particularly metal alkoxides and diketonates.

Additional Commentaries and remarks

Patents

Southeast TechInventures, Inc.

Benj — Thu, 05 Apr 2007 13:58:38 +0000

Ticker Id

Web url

http://www.southeasttechinventures.com/

Contact Email

info@southeasttechinventures.com

Short description

Street address

7030 Kit Creek Rd., STE 250

Zip or postal code

27560

Telephone

919-941-6080

Fax

919-941-6087

Foundation date

Ceo, president

Number of employees

Long description

STI partners with universities, government funding agencies, private investors, and corporate entities to provide the structure, processes and funding needed to successfully bring new technologies to market.

For any given STI portfolio technology, STI's operating model and experience guides and supports the new entity quickly along the path to commercialization. Activities provided by STI may include the following:

* Obtaining an intellectual property license from the applicable university
* Assisting in further developing the technology in partnership with the inventors
* Establishing the entity as a spin-off company
* Providing financing contacts
* Providing experienced business guidance and mentorship

How Can STI Benefit You?
STI directly benefits university inventors by maximizing return on intellectual property. STI does this by providing grant and funding support, engineering and development assistance, company infrastructure support (company incorporation, business process guidelines structural advice), and other necessities for IP commercialization.

STI generates additional revenue for universities via licensing and royalty fees and helps attract and retain talented faculty by having a vehicle to place their ideas into the marketplace.

STI directly benefits investors by providing early access to many advanced but as of yet unseen technologies. Doing so maximizes ROI by allowing investors to learn about a vast array of technologies via a single relationship with STI.

STI directly benefits corporations by bridging research with corporate partners, providing a first look at university technology, and accelerating time to market.

Additional Commentaries and remarks

Patents

Ziptronix, Inc.

Benj — Tue, 22 Aug 2006 11:57:27 +0000

Ticker Id

Web url

http://www.ziptronix.com/

Contact Email

Short description

Street address

800 Perimeter Park Drive, Suite B

Zip or postal code

27560

Telephone

919.459.2400

Fax

919.459.2401

Foundation date

Ceo, president

Number of employees

Long description

Additional Commentaries and remarks

Patents

BioDelivery Sciences International

Benj — Thu, 24 Aug 2006 16:49:21 +0000

Ticker Id

Web url

http://www.biodeliverysciences.com/

Contact Email

bdsi-info@bdsinternational.com

Short description

Street address

2501 Aerial Center Parkway, Suite 205

Zip or postal code

27560

Telephone

919 653-5160

Fax

919 653-5161

Foundation date

Ceo, president

Number of employees

Long description

We are a biotechnology company developing a novel, revolutionary drug delivery system. Our patented cochleate-based BioralTechnology (Smart Pharmaceuticals) allows biopharmaceutical manufacturers to offer biologically-active compounds with unparalleled convenience, shelf-life, and reduced side effects.

BDSI is applying its drug delivery technology to generic, off-patent injectable drugs and making them patent-protected, oral drugs. BDSI has developed Amphotericin B, the worlds leading antifungal with global sales of $1 billion, into a patent-protected orally-deliverable pharmaceutical ready for clinical trials (Bioral Amphotericin B).

BDSI has demonstrated that the application of the Bioral drug delivery technology to one of its patented, intravenous drugs makes it possible to orally deliver the drug with superior performance in an animal model.

Application of the company's Bioral technology is an effective patent-extension strategy for some pharmaceuticals approaching patent expiration and, as opposed to other technologies, it potentially offers additional clinical benefits such as enhanced effectiveness and reduced side-effects.